Back to top

Bank of America Securities Sticks to Their Hold Rating for Arcus Biosciences (RCUS)

Bank of America Securities analyst Jason Zemansky reiterated a Hold rating on Arcus Biosciences today and set a price target of $29.00. According t...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Arcus Biosciences, Inc. (RCUS)